Company Profile
EyePoint Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- EYPT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
14.28 USD (-2.99%)
Close
Last updated: July 13, 2026 at 00:00
1.23B USD
Market cap
Why the stock is moving
EYPT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
EyePoint Pharmaceuticals is an ophthalmology-focused biopharmaceutical company centered on eye-disease programs where clinical validation and specialty adoption drive the narrative.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, EyePoint Pharmaceuticals is followed within the ophthalmology universe for its exposure to specialty-treatment catalysts and clinical milestones.
Business Model Characteristics
EyePoint Pharmaceuticals is a specialty-disease story where pipeline execution, physician adoption, and label progress shape how investors value the company.
Position Within the Biotechnology Landscape
Compared with larger diversified peers, EyePoint Pharmaceuticals sits closer to the catalyst-driven side of the landscape, where ophthalmology updates can shift expectations quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of EyePoint Pharmaceuticals (EYPT)?
EyePoint Pharmaceuticals (EYPT) most recently closed at 14.28 USD, a -2.99% move versus the previous session.
What is the market cap of EyePoint Pharmaceuticals (EYPT)?
EyePoint Pharmaceuticals currently has a market capitalization of 1.23B USD on BioPharmSignal.
What does EyePoint Pharmaceuticals do?
EyePoint Pharmaceuticals is an ophthalmology-focused biopharmaceutical company centered on eye-disease programs where clinical validation and specialty adoption drive the narrative.
On which exchange is EYPT stock listed?
EyePoint Pharmaceuticals (EYPT) is associated with NASDAQ, United States, Biotechnology.
What is EyePoint?
EyePoint Pharmaceuticals is an ophthalmology-focused biopharmaceutical company centered on eye-disease programs where clinical validation and specialty adoption drive the narrative.
Which conditions is EyePoint Pharmaceuticals targeting with EyePoint?
EyePoint Pharmaceuticals is associated with ophthalmology based on its company overview and current catalyst commentary.
What is Pharmaceuticals?
EyePoint Pharmaceuticals is an ophthalmology-focused biopharmaceutical company centered on eye-disease programs where clinical validation and specialty adoption drive the narrative.